Exhibit 99.1 CVRx Reports Third Quarter 2024 Financial and Operating Results MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the third quarter of 2024. Recent Highlights · Total revenue for the third quarter 2024 was $13.4 million, an increas ...